Free Paper Sessions

Video

Free Paper 8 – Diabetes & Vascular Diseases: Long-term complications of Sickle cell retinopathy and outcomes

Speaker(s): Roslyn Manrique

Video

Free Paper 3 – AMD: Artificial Intelligence-Based Fluid Quantification in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treated with Faricimab – A real-life study

Speaker(s): Boris Stanzel

Video

Free Paper 8 – Diabetes & Vascular Diseases: Retinal capillary nonperfusion in advanced stages of NPDR: The RICHARD study

Speaker(s): Antonio Martinho

Video

Free Paper 3 – AMD: A 96-week PULSAR subgroup analysis: Similar visual and anatomic improvements with aflibercept 8 mg every 12 weeks or longer and 2 mg every 8 weeks, as defined by baseline BCVA, CRT, CNV type, and race

Speaker(s): Jean-François Korobelnik

Video

Free Paper 8 – Diabetes & Vascular Diseases: Long-term efficacy and Safety of CT-P42 compared to Reference Aflibercept in Diabetic Macular Edema: 52-Week Results from the Phase 3 CT-P42 3.1

Speaker(s): Sebastian Wolf

2024 Barcelona

Free Paper 3 – AMD: AI-based qOCT analysis of phase 3 trials OAKS & DERBY data on the effect of pegcetacoplan on geographic atrophy

Speaker(s): Pallavi Bagga

Video

Free Paper 8 – Diabetes & Vascular Diseases: Six-month progression of capillary nonperfusion in advanced stages of nonproliferative diabetic retinopathy: The RICHARD study

Speaker(s): Inês Pereira Marques

Video

Free Paper 3 – AMD: Clinical characteristics and progression rates of geographic atrophy in a multiethnic Asian population from Singapore

Speaker(s): Farah Nur Ilyana Mohd Ibrahim

Video

Free Paper 8 – Diabetes & Vascular Diseases: EYE DMI: the largest real-world study to examine the prevalence and 1 year progression of macular non-perfusion in people with diabetic retinopathy

Speaker(s): Peter Scanlon

Video

Free Paper 3 – AMD: Monitoring treatment efficacy of GA secondary to AMD using AI-prediction and assessment of intra-individual fellow eye predictors

Speaker(s): Gregor Reiter

Video

Free Paper 8 – Diabetes & Vascular Diseases: Efficacy and safety of the low dose dexamethasone IBE-814 IVT Implant for diabetic macular edema and retinal vein occlusion: Results of a first-in-human Phase 2 trial

Speaker(s): Hemal Mehta

2024 Barcelona

Free Paper 3 – AMD: Evaluating the use of 3-dimensional volumetric OCT data to accurately segment area of geographic atrophy secondary to age-related macular degeneration: The GEODE Study

Speaker(s): Simrat Sodhi

Video

Free Paper 8 – Diabetes & Vascular Diseases: The Real-World Efficacy and Safety of Faricimab in Diabetic Macular Edema: First Time One Year Results of the TAHOE Study

Speaker(s): David Almeida

Video

Free Paper 3 – AMD: 56-week results from the TALON open-label extension, a Phase IIIb/IV study of brolucizumab in a Treat-and-Extend regimen with maximum treatment intervals up to 20 weeks in patients with neovascular age-related macular degeneration

Speaker(s): Peter J Kertes

2024 Barcelona

Free Paper 8 – Diabetes & Vascular Diseases: Faricimab in DME: Results From the RHONE-X Long-Term Extension Trial

Speaker(s): Patricio Schlottmann